How can the NLRP3 inflammasome can be exploited to slow the decline associated with Alzheimer's disease?

The pharma industry is one of the biggest targets for cybercrime. How can companies avoid succumbing to attack?

Sitting Down With… Evelina Vågesjö, Chief Executive Officer at Ilya Pharma, Sweden.

On the 70th anniversary of death Henrietta Lacks, we examine her contributions to science and what they mean for modern research.

Though mRNA technologies are helping to expand the industry's horizons, there manufacture does come with challenges.

Applying mRNA technology to the treatment of malaria.

How a drug approval changed the lives of patients living with rare disease.

What milestones will define the next era in the mRNA story?

What strategies can pharma employ to protect itself against cyber threats?

The EMA releases its annual report highlighting its achievements throughout 2020.